Stroke and Vascular Neurology

Papers
(The TQCC of Stroke and Vascular Neurology is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Dural sinus septum: an underlying cause of cerebral venous sinus stenting failure and complications282
CerebrAlcare Pills on CereBral Small VesseL DiseasE (CABLE) trial: rationale and design79
Photochemically induced thalamus infarction impairs cognition in a mouse model59
Efficacy and safety of Y-3 intracalvariosseous injection versus intravenous injection in the treatment of acute large hemispheric infarction (SOLUTION-2): rationale and design of a multicentre, prospe50
Multiomics genetic insights into potential molecular targets for intracranial aneurysm44
MetS in the prediction of asymptomatic intracranial arterial stenosis: the potential mediating role of hsCRP42
Contact aspiration versus stent retriever thrombectomy for acute basilar artery occlusion (ANGEL-COAST): rationale and design of a multicentre, prospective, randomised, open-label, blinded-endpoint tr39
Carotid artery endarterectomy in patients with symptomatic non-stenotic carotid artery disease37
Mechanical thrombectomy with combined stent retriever and contact aspiration versus stent retriever alone for acute large vessel occlusion: data from ANGEL-ACT registry35
Oxidised low-density lipoprotein and adverse outcome in patients with acute mild ischaemic stroke or high-risk TIA: a secondary analysis of the INSPIRES randomised clinical trial35
Letter to the editor: risk factors for cervical artery dissection – a systematic review with meta-analysis29
Efficacy of immediate anti-hypertensive treatment in patients with acute ischaemic stroke stratified by mean arterial pressure and pulse pressure: a secondary analysis of the China Antihypertensive Tr27
Loberamisal injection for the treatment of acute ischaemic stroke: a multicentre, randomised, double-blind, placebo-controlled phase II clinical trial26
Prediction of futile recanalisation after endovascular treatment in acute ischaemic stroke: development and validation of a hybrid machine learning model26
KRAS mutation-induced EndMT of brain arteriovenous malformation is mediated through the TGF-β/BMP-SMAD4 pathway23
Intravenous tenecteplase compared with alteplase for minor ischaemic stroke: a secondary analysis of the AcT randomised clinical trial23
Acute right insular ischaemic lesions and poststroke left ventricular dysfunction23
Stepwise improvement in intracerebral haematoma expansion prediction with advanced imaging: a comprehensive comparison of existing scores23
Characteristics, temporal trends and outcomes of intravenous thrombolysis in Chinese patients aged>80 years who had a stroke23
Pipeline Embolization Device for intracranial aneurysms presenting with mass effect: a large Chinese cohort22
Tongxinluo capsule in the treatment of cerebral small vessel disease: protocol of a randomised, double-blind, placebo-controlled, multicentre clinical study (TOPS-CSVD)22
Frequency, predictors and cardiovascular outcomes associated with transthoracic echocardiographic findings during acute ischaemic stroke hospitalisation21
Indobufen versus aspirin in acute ischaemic stroke (INSURE): rationale and design of a multicentre randomised trial21
Detailed phenotype of RNF213 p.R4810K variant identified by the Chinese patients with acute ischaemic stroke or transient ischaemic attack20
Endovascular treatment for basilar artery occlusion: a meta-analysis19
Poststroke motor, cognitive and speech rehabilitation with brain–computer interface: a perspective review19
Thrombus migration in patients with acute ischaemic stroke undergoing endovascular thrombectomy19
LRRC8A in endothelial cells contributes to the aberrant blood-brain barrier integrity in ischaemic stroke19
Head-down position after reperfusion improves cerebral ischaemic injury in rat18
Development of machine learning-based models to predict 10-year risk of cardiovascular disease: a prospective cohort study18
Angioarchitecture and prognosis of pediatric intracranial pial arteriovenous fistula18
Ten-year follow-up investigation of stroke risk in systemic lupus erythematosus17
Discontinuation of antiplatelet therapy after stent-assisted coil embolisation of cerebral aneurysm: a nationwide cohort study17
CCL17 exerts neuroprotection through activation of CCR4/mTORC2 axis in microglia after subarachnoid haemorrhage in rats17
Low LDL-C level and intracranial haemorrhage risk after ischaemic stroke: a prospective cohort study16
Arteriolosclerosis differs from venular collagenosis in relation to cerebrovascular parenchymal damages: an autopsy-based study16
Treatment with intravenous alteplase in ischaemic stroke patients with onset time between 4.5 and 24 hours (HOPE): protocol for a randomised, controlled, multicentre study16
Extracellular vesicles bearing serum amyloid A1 exacerbate neuroinflammation after intracerebral haemorrhage15
STING mediates microglial pyroptosis via interaction with NLRP3 in cerebral ischaemic stroke15
Endovascular therapy in acute anterior circulation large vessel occlusive patients with a large infarct core (ANGEL-ASPECT): protocol of a multicentre randomised trial15
Quantitative histopathological analysis of thrombi retrieved by mechanical thrombectomy and their association with stroke aetiology14
Enhanced diagnostic workup increases pathological findings in patients with acute ischaemic stroke: results of the prospective HEBRAS study14
Src inhibition rescues FUNDC1-mediated neuronal mitophagy in ischaemic stroke14
Racial disparities in access to, and outcomes of, acute ischaemic stroke treatments in the USA14
Cerebrovascular cinematic rendering of multisystemic smooth muscle dysfunction syndrome13
Thrombolytic agents, more options, more challenges13
Baseline systolic blood pressure and efficacy of dual antiplatelet in acute ischaemic stroke13
Central post-stroke pain: advances in clinical and preclinical research13
Development, validation and comparison of multivariable risk scores for prediction of total stroke and stroke types in Chinese adults: a prospective study of 0.5 million adults13
Loberamisal for Acute Ischaemic Stroke (LAIS): a multicentre, randomised, double-blind, parallel, placebo-controlled phase III clinical trial12
Rationale and design of Low-Frequency REpetitive TRanscranial Magnetic Stimulation Combined with Endovascular Treatment in ACute Ischaemic StrokE (RETRACE II): a randomised double-blind controlled mul12
Incidence and predictors of futile recanalisation after endovascular therapy in acute vertebrobasilar artery occlusion patients: insight from the ANGEL-ACT registry12
Rationale and design of the GOLDEN BRIDGE II: a cluster-randomised multifaceted intervention trial of an artificial intelligence-based cerebrovascular disease clinical decision support system to impro12
Sex differences in the epidemiology of spontaneous and traumatic cervical artery dissections12
Inflammatory biomarkers and cerebral small vessel disease: a community-based cohort study11
Secondary stroke evaluation in patients admitted for CRAO in a large national inpatient sample11
BEST-BAO: a multicentre, prospective, randomised controlled trial of endovascular treatment with or without intravenous thrombolysis in acute ischaemic stroke due to basilar artery occlusion – study p11
Dual regulation of Atf3 and Lonp1 as therapeutic targets in cerebral ischaemia-reperfusion injury11
Brain-targeted extracellular vesicles for anti-cuproptosis therapy in subarachnoid haemorrhage11
Advance Consent for participation in Acute Stroke Trials (ACTION): protocol for a feasibility study11
Retrograde recanalisation for vertebral artery stump syndrome: a case report11
Early blood pressure lowering and cerebral oedema in thrombolysis-treated stroke: secondary analysis of the ENCHANTED trial11
DRug-coated Balloon for Endovascular treatment of sYmptOmatic intracraNial stenotic Disease (DR. BEYOND): the protocol of a multicentre randomised trial11
Outcomes of Onyx embolisation as primary treatment for intracranial dural arteriovenous fistulas over the past two decades10
Cerebral haemodynamics in symptomatic intracranial atherosclerotic disease: a narrative review of the assessment methods and clinical implications10
Surgical timing and long-term outcomes in patients with severe haemorrhagic spinal cord cavernous malformations10
Clinical utility of measuring circulating glial fibrillary acidic protein in severe stroke10
Loss of life expectancy due to stroke and its subtypes in urban and rural areas in China, 2005–202010
Definitions of white matter hyperintensity change: impact on estimates of progression and regression10
CSA declaration of next-generation reperfusion therapy for ischaemic stroke10
Association between statin therapy and the risk of stroke in patients with moyamoya disease: a nationwide cohort study10
Exosomes-mediated delivery of miR-486-3p alleviates neuroinflammation via SIRT2-mediated inhibition of mitophagy after subarachnoid hemorrhage10
Exploring the relationship between embolic acute stroke distribution and supra-aortic vessel patency: key findings from an in vitro model study10
Efficacy of butylphthalide in preventing cognitive decline in ischaemic stroke survivors: a 12-month prospective following-up study9
Safety and efficacy of glibenclamide on cerebral oedema following aneurysmal subarachnoid haemorrhage: a randomised, double-blind, placebo-controlled clinical trial9
Intra-arterial thrombolytics during endovascular thrombectomy for acute ischaemic stroke in the MR CLEAN Registry9
Oestrogen ameliorates blood-brain barrier damage after experimental subarachnoid haemorrhage via the SHH pathway in male rats9
Antithrombotic therapy in patients with COVID-19: indications, pharmacotherapy and controversy9
Dl-3-n-butylphthalide attenuates brain injury caused by cortical infarction accompanied by cranial venous drainage disturbance9
Cisternostomy for malignant middle cerebral artery infarction: proposed pathophysiological mechanisms and preliminary results9
Comparison of the Pipeline embolisation device alone or combined with coiling for treatment of different sizes of intracranial aneurysms9
Incidence and prevalence of vascular cognitive impairment in China: a systematic review and meta-analysis9
Rationale and design of a randomised double-blind 2×2 factorial trial comparing the effect of a 3-month intensive statin and antiplatelet therapy for patients with acute mild ischaemic stroke or high-9
Preclinical evaluation of ZL006-05, a new antistroke drug with fast-onset antidepressant and anxiolytic effects8
Phase I dose-escalation study of tenecteplase, a third-generation fibrinolytic agent, combined with neuronavigation-assisted stereotactic minimally invasive puncture, in patients with acute spontaneou8
VasCog Screen test: sensitive in detecting cognitive impairment in patients who had a stroke or with heart failure8
Real-world analysis of two ischaemic stroke and TIA systolic blood pressure goals on 12-month mortality and recurrent vascular events8
COP27 climate change conference: urgent action needed for Africa and the world8
Improving detection of cerebral small vessel disease aetiology in patients with isolated lobar intracerebral haemorrhage8
Associations of accelerated biological ageing with incident dementia, cognitive functions and brain structure: a prospective cohort study based on UK Biobank8
Effect of intravenous alteplase before endovascular therapy for atherothrombotic stroke-related large vessel occlusion: subanalysis of the RESCUE AT-LVO registry8
Neuronavigation-assisted stereotactic minimally invasive puncture with tenecteplase for the treatment of acute spontaneous deep intracerebral haemorrhage (NAS-TNK): rationale and design of a multicent8
Correction: Cilostazol and isosorbide mononitrate for the prevention of progression of : baseline data and statistical analysis plan for the Lacunar Intervention Trial-2 (LACI-2) (ISRCTN14911850)8
Young stroke in Bangladesh: addressing rare cases with diagnostic challenges and much-needed solutions8
0.58778214454651